Submitted by Anonymous (not verified) on 12 June 2026 - 14:32
Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 14, Status: Authorised